Clinical Trial

Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
BiCAP-201 trial offers continued access to Bicycle investigational product treatments zelenectide pevedotin, nuzefatide pevedotin, and BT7480 for participants currently receiving and deriving clinical benefit from one of these treatments in a Bicycle Therapeutics-sponsored clinical trial. Bicycle Therapeutics will continue to monitor longer term safety of these treatments.
Trial Details
NCT Number NCT07681674
Lead Sponsor BicycleTx Limited
Conditions Advanced Solid Tumors
Enrollment 16 participants
Start Date 2026-08-01
Primary Completion 2030-05-30 (estimated)
Study Completion 2030-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-02